Figure 1
Patient characteristics. A total of 20 (N) patients were enrolled. Among them, a total of 20 participants (100%) completed an evaluation at week 6. Among them, a total of 13 (n2) participants (65%) had a response to the pharmaceutical treatment and five (m2) participants (25%) were in remission at week 6. The patient characteristics are summarized.